References
- Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, Sadda SR, Sebag J, Spaide RF, Stalmans P. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013; 120(12):2611–2619.
- Panozzo G, Cicinelli MV, Augustin AJ, Battaglia Parodi M, Cunha-Vaz J, Guarnaccia G, Kodjikian L, Jampol LM, Jünemann A, Lanzetta P, et al. An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: The European School for Advanced Studies in Ophthalmology classification. Eur J Ophthalmol. 2020; 30(1):8–18.
- Hsieh YT, Yang CM. Vitreomacular traction in diabetic retinopathy. Jpn J Ophthalmol. 2024; 68(1):12–18.
- Johnson MW. Posterior vitreous detachment: evolution and complications of its early stages. Am J Ophthalmol. 2010; 149(3):371–82.
- Rios Gonzalez R, Villegas VM, Blasini M. Bilateral vitreomacular traction syndrome associated with topical pilocarpine 1% ophthalmic solution. Am J Ophthalmol Case Rep. 2023; 13;30:101834.
- Charbonnel J, Glacet-Bernard A, Korobelnik JF, Nyouma-Moune E, Pournaras CJ, Colin J, Coscas G, Soubrane G. Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol. 2004; 242(3):223–8.
- Johnson TM, Vaughn CW, Glaser BM. Branch retinal vein occlusion associated with vitreoretinal traction. Can J Ophthalmol. 2006; 41(5):600–2.
- Ascaso FJ, Padgett E, Núñez E, Villén L, Grzybowski A, Cristóbal JA. Branch retinal vein occlusion and vitreovascular traction: a preliminary spectral domain OCT case-control study. Graefes Arch Clin Exp Ophthalmol. 2014; 252(3):375–81.
- Hikichi T, Yoshida A, Trempe CL. Course of vitreomacular traction syndrome. Am J Ophthalmol. 1995; 119(1):55–61.
- Nawrocka ZA, Nawrocka Z, Nawrocki J. Swept-Source Optical Coherence Tomography Angiography in Vitreomacular Traction Syndrome. J Vitreoretin Dis. 2021; 6(1):31–39.
- Petrou P, Chalkiadaki E, Errera MH, Liyanage S, Wickham L, Papakonstantinou E, Karamaounas A, Kanakis M, Georgalas I, Kandarakis S, et al. Factors associated with the clinical course of vitreomacular traction. J Ophthalmol. 2020; 2020:9457670.
- Haines NR, Manoharan N, Olson JL, D’Alessandro A, Reisz JA. Metabolomics analysis of human vitreous in diabetic retinopathy and rhegmatogenous retinal detachment. J Proteome Res. 2018; 17(7):2421–2427.
- Hu Huang; Pentosephosphate pathway and diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2023; 64(8):1823.
- Lin A, Xia H, Zhang A, Liu X, Chen H. Vitreomacular interface disorders in proliferative diabetic retinopathy: An optical coherence tomography study. J Clin Med. 2022; 11(12):3266.
- Li X, Luo X, Lu X, Duan J, Xu G. Metabolomics study of diabetic retinopathy using gas chromatography-mass spectrometry: A comparison of stages and subtypes diagnosed by Western and Chinese medicine. Mol Biosyst. 2011; 7(7):2228–37.
- Klaassen I, van Geest RJ, Kuiper EJ, van Noorden CJ, Schlingemann RO. The role of CTGF in diabetic retinopathy. Exp Eye Res. 2015; 133:37–48.
- Hayashi K, Sato T, Manabe SI, Hirata A, Yoshimura K. Posterior vitreous detachment in patients with diabetes mellitus. Jpn J Ophthalmol. 2020; 64(2):187–195.
- Browning DJ, Stewart MW, Lee C. Diabetic macular edema: Evidence-based management. Indian J Ophthalmol. 2018; 66(12):1736–1750.
- Sorour OA, Levine ES, Baumal CR, Elnahry AG, Braun P, Girgis J, Waheed NK. Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods. Surv Ophthalmol. 2023; 68(2):147–174.
- Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A, Lopez-Galvez M, Navarro-Gil R, Verges R. Diabetic macular edema pathophysiology: Vasogenic versus inflammatory. J Diabetes Res. 2016;2016:2156273.
- Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015; 372(13):1193–203.
- Rotsos TG, Moschos MM. Cystoid macular edema. Clin Ophthalmol. 2008; 2(4):919–30.
- Wilson DS, Pinto AM, Gupta RR. Pars plana vitrectomy for vitreomacular traction resulting in persistent postoperative loculated foveal subretinal fluid. J VitreoretinDis. 2023; 7(6):552–556.
- Kumar N, Al Kandari J, Al Sabti K, Wani VB. Partial-thickness macular hole in vitreomacular traction syndrome: a case report and review of the literature. J Med Case Rep. 2010; 4:7.
- Tayyab M, Iqbal K, Abid MA, Ur Rahman F, Tayyab HA. Surgical outcome of vitreomacular traction associated with macular hole. Cureus. 2022; 14(12):e32620.
- Joondeph BC, Willems P, Raber T, Duchateau L, Markoff J. Prognostic factors associated with ocriplasmin efficacy for the treatment of symptomatic vitreomacular adhesion and full-thickness macular hole: Analysis from four studies. J Ophthalmic Vis Res. 2021; 16(1):42–55.
- Bennison C, Stephens S, Lescrauwaet B, Van Hout B, Jackson TL. Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole. J Mark Access Health Policy. 2016; 4.
- Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S, Haller JA; MIVI-TRUST Study Group. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med. 2012; 367(7):606–15.
- Jackson TL, Haller J, Blot KH, Duchateau L, Lescrauwaet B. Ocriplasmin for treatment of vitreomacular traction and macular hole: A systematic literature review and individual participant data meta-analysis of randomized, controlled, double-masked trials. Surv Ophthalmol. 2022; 67(3):697–711.